<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="44185">Methotrexate</z:chebi> pharmacokinetic studies, performed on a patient with <z:e sem="disease" ids="C0341697" disease_type="Disease or Syndrome" abbrv="">renal impairment</z:e> who had toxic effects following 20 mg/sq m of intrathecally administered <z:chebi fb="0" ids="44185">methotrexate</z:chebi>, demonstrated prolonged serum concentrations of the drug, which accounted for the condition </plain></SENT>
<SENT sid="1" pm="."><plain>After the return of <z:mpath ids='MPATH_458'>normal</z:mpath> renal function, pharmacokinetic studies were repeated following the same dose and route of administration of <z:chebi fb="0" ids="44185">methotrexate</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>On this occasion there was a rapid clearance of serum <z:chebi fb="0" ids="44185">methotrexate</z:chebi> below toxic levels </plain></SENT>
</text></document>